been

** A UK government review is underway after an investigation found widespread errors in patient leaflets for dopamine agonist medications, which are used to treat conditions like Parkinson’s disease and restless legs syndrome. The Medicines and Healthcare products Regulatory Agency (MHRA) aims to ensure accurate and up-to-date information is provided to patients.